{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:19:39Z","timestamp":1773659979440,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,11]],"date-time":"2016-07-11T00:00:00Z","timestamp":1468195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,7,11]],"date-time":"2016-07-11T00:00:00Z","timestamp":1468195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The spread of artemisinin-resistant parasites could lead to higher incidence of patients with malaria complications. However, there are no current treatments that directly dislodge sequestered parasites from the microvasculature. We show that four common antiplasmodial drugs do not disperse rosettes (erythrocyte clusters formed by malaria parasites) and therefore develop a cell-based high-throughput assay to identify potential rosette-disrupting compounds. A pilot screen of 2693 compounds identified Malaria Box compound MMV006764 as a potential candidate. Although it reduced rosetting by a modest 20%, MMV006764 was validated to be similarly effective against both blood group O and A rosettes of three laboratory parasite lines. Coupled with its antiplasmodial activity and drug-likeness, MMV006764 represents the first small-molecule compound that disrupts rosetting and could potentially be used in a resource-limited setting to treat patients deteriorating rapidly from malaria complications. Such dual-action drugs that simultaneously restore microcirculation and reduce parasite load could significantly reduce malaria morbidity and mortality.<\/jats:p>","DOI":"10.1038\/srep29317","type":"journal-article","created":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T12:59:28Z","timestamp":1468328368000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Rosette-Disrupting Effect of an Anti-Plasmodial Compound for the Potential Treatment of Plasmodium falciparum Malaria Complications"],"prefix":"10.1038","volume":"6","author":[{"given":"Jun-Hong","family":"Ch\u2019ng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"Moll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria del Pilar","family":"Quintana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherwin Chun Leung","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Masters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernest","family":"Moles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders B.","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Wahlgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,11]]},"reference":[{"key":"BFsrep29317_CR1","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S1474-4422(10)70270-2","volume":"9","author":"GL Birbeck","year":"2010","unstructured":"Birbeck, G. L. et al. Blantyre Malaria Project Epilepsy Study (BMPES) of neurological outcomes in retinopathy-positive paediatric cerebral malaria survivors: a prospective cohort study. The Lancet. Neurology 9, 1173\u20131181, 10.1016\/S1474-4422(10)70270-2 (2010).","journal-title":"The Lancet. Neurology"},{"key":"BFsrep29317_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1203\/00006450-201011001-0052410.1203\/PDR.0b013e3181eee738","volume":"68","author":"R Idro","year":"2010","unstructured":"Idro, R., Marsh, K., John, C. C. & Newton, C. R. Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatric research 68, 267\u2013274, 10.1203\/00006450-201011001-0052410.1203\/PDR.0b013e3181eee738 (2010).","journal-title":"Pediatric research"},{"key":"BFsrep29317_CR3","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1182\/blood.V78.3.812.812","volume":"78","author":"DK Kaul","year":"1991","unstructured":"Kaul, D. K., Roth, E. F. Jr., Nagel, R. L., Howard, R. J. & Handunnetti, S. M. Rosetting of Plasmodium falciparum-infected red blood cells with uninfected red blood cells enhances microvascular obstruction under flow conditions. Blood 78, 812\u2013819 (1991).","journal-title":"Blood"},{"key":"BFsrep29317_CR4","doi-asserted-by":"publisher","first-page":"987","DOI":"10.4269\/ajtmh.2009.09-0406","volume":"81","author":"OK Doumbo","year":"2009","unstructured":"Doumbo, O. K. et al. High levels of Plasmodium falciparum rosetting in all clinical forms of severe malaria in African children. Am J Trop Med Hyg 81, 987\u2013993, 10.4269\/ajtmh.2009.09-0406 (2009).","journal-title":"Am J Trop Med Hyg"},{"key":"BFsrep29317_CR5","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1111\/cmi.12183","volume":"15","author":"JD Smith","year":"2013","unstructured":"Smith, J. D., Rowe, J. A., Higgins, M. K. & Lavstsen, T. Malaria\u2019s deadly grip: cytoadhesion of Plasmodium falciparum-infected erythrocytes. Cell Microbiol 15, 1976\u20131983, 10.1111\/cmi.12183 (2013).","journal-title":"Cell Microbiol"},{"key":"BFsrep29317_CR6","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nm.3812","volume":"21","author":"S Goel","year":"2015","unstructured":"Goel, S. et al. RIFINs are adhesins implicated in severe Plasmodium falciparum malaria. Nat Med 21, 314\u2013317, 10.1038\/nm.3812 (2015).","journal-title":"Nat Med"},{"key":"BFsrep29317_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.chom.2014.06.004","volume":"16","author":"M Niang","year":"2014","unstructured":"Niang, M. et al. STEVOR is a Plasmodium falciparum erythrocyte binding protein that mediates merozoite invasion and rosetting. Cell host & microbe 16, 81\u201393, 10.1016\/j.chom.2014.06.004 (2014).","journal-title":"Cell host & microbe"},{"key":"BFsrep29317_CR8","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1182\/blood-2013-12-541698","volume":"123","author":"WC Lee","year":"2014","unstructured":"Lee, W. C. et al. Glycophorin C (CD236R) mediates vivax malaria parasite rosetting to normocytes. Blood 123, e100\u2013109, 10.1182\/blood-2013-12-541698 (2014).","journal-title":"Blood"},{"key":"BFsrep29317_CR9","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S0035-9203(98)90901-4","volume":"92","author":"BS Lowe","year":"1998","unstructured":"Lowe, B. S., Mosobo, M. & Bull, P. C. All four species of human malaria parasites form rosettes. Trans R Soc Trop Med Hyg 92, 526 (1998).","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"BFsrep29317_CR10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/srep00118","volume":"1","author":"B Malleret","year":"2011","unstructured":"Malleret, B. et al. A rapid and robust tri-color flow cytometry assay for monitoring malaria parasite development. Sci Rep 1, 118, 10.1038\/srep00118 (2011).","journal-title":"Sci Rep"},{"key":"BFsrep29317_CR11","doi-asserted-by":"publisher","first-page":"e113248","DOI":"10.1371\/journal.pone.0113248","volume":"9","author":"L Albrecht","year":"2014","unstructured":"Albrecht, L. et al. B-Cell Epitopes in NTS-DBL1alpha of PfEMP1 Recognized by Human Antibodies in Rosetting Plasmodium falciparum. PLoS One 9, e113248, 10.1371\/journal.pone.0113248 (2014).","journal-title":"PLoS One"},{"key":"BFsrep29317_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1006\/expr.1998.4349","volume":"91","author":"A Barragan","year":"1999","unstructured":"Barragan, A., Spillmann, D., Kremsner, P. G., Wahlgren, M. & Carlson, J. Plasmodium falciparum: molecular background to strain-specific rosette disruption by glycosaminoglycans and sulfated glycoconjugates. Exp Parasitol 91, 133\u2013143, 10.1006\/expr.1998.4349 (1999).","journal-title":"Exp Parasitol"},{"key":"BFsrep29317_CR13","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/infdis\/jiu589","volume":"211","author":"J Gullingsrud","year":"2015","unstructured":"Gullingsrud, J. et al. High-throughput screening platform identifies small molecules that prevent sequestration of Plasmodium falciparum-infected erythrocytes. J Infect Dis 211, 1134\u20131143, 10.1093\/infdis\/jiu589 (2015).","journal-title":"J Infect Dis"},{"key":"BFsrep29317_CR14","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/0140-6736(90)93174-N","volume":"336","author":"J Carlson","year":"1990","unstructured":"Carlson, J. et al. Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet 336, 1457\u20131460 (1990).","journal-title":"Lancet"},{"key":"BFsrep29317_CR15","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1182\/blood.V84.11.3909.bloodjournal84113909","volume":"84","author":"J Carlson","year":"1994","unstructured":"Carlson, J., Nash, G. B., Gabutti, V., al-Yaman, F. & Wahlgren, M. Natural protection against severe Plasmodium falciparum malaria due to impaired rosette formation. Blood 84, 3909\u20133914 (1994).","journal-title":"Blood"},{"key":"BFsrep29317_CR16","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1128\/iai.63.6.2323-2326.1995","volume":"63","author":"A Rowe","year":"1995","unstructured":"Rowe, A., Obeiro, J., Newbold, C. I. & Marsh, K. Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect Immun 63, 2323\u20132326 (1995).","journal-title":"Infect Immun"},{"key":"BFsrep29317_CR17","unstructured":"Moll, K., Kaneko, A., Scherf, A. & Wahlgren, M. Methods in Malaria Research (6th Edition). (EviMalaR, Glasgow, UK & MR4\/ATCC, Manassas, VA, USA, 2013, 2014)."},{"key":"BFsrep29317_CR18","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/cyto.1171","volume":"46","author":"RP Wersto","year":"2001","unstructured":"Wersto, R. P. et al. Doublet discrimination in DNA cell-cycle analysis. Cytometry 46, 296\u2013306 (2001).","journal-title":"Cytometry"},{"key":"BFsrep29317_CR19","unstructured":"Houtz, B., Trotter, J. & Sasaki, D. BD FACService TECHNOTES Special Sorting Issue. (2004) Available at: http:\/\/www.bdbiosciences.com\/documents\/BD_Research_Sorting_TechBulletin.pdf. (Accessed: 9 May 2016)."},{"key":"BFsrep29317_CR20","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/cyto.a.20764","volume":"75","author":"OR Hughes","year":"2009","unstructured":"Hughes, O. R., Stewart, R., Dimmick, I. & Jones, E. A. A critical appraisal of factors affecting the accuracy of results obtained when using flow cytometry in stem cell investigations: where do you put your gates? Cytometry. Part A : the journal of the International Society for Analytical Cytology 75, 803\u2013810, 10.1002\/cyto.a.20764 (2009).","journal-title":"Cytometry. Part A : the journal of the International Society for Analytical Cytology"},{"key":"BFsrep29317_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/bmb\/ldh059","volume":"75\u201376","author":"G Pasvol","year":"2005","unstructured":"Pasvol, G. The treatment of complicated and severe malaria. Br Med Bull 75\u201376, 29\u201347, 10.1093\/bmb\/ldh059 (2005).","journal-title":"Br Med Bull"},{"key":"BFsrep29317_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.molbiopara.2009.09.007","volume":"169","author":"KR Hughes","year":"2010","unstructured":"Hughes, K. R., Biagini, G. A. & Craig, A. G. Continued cytoadherence of Plasmodium falciparum infected red blood cells after antimalarial treatment. Mol Biochem Parasitol 169, 71\u201378, 10.1016\/j.molbiopara.2009.09.007 (2010).","journal-title":"Mol Biochem Parasitol"},{"key":"BFsrep29317_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0140-6736(72)90621-6","volume":"1","author":"N Jaroonvesama","year":"1972","unstructured":"Jaroonvesama, N. Intravascular coagulation in falciparum malaria. Lancet 1, 221\u2013223 (1972).","journal-title":"Lancet"},{"key":"BFsrep29317_CR24","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1136\/bmj.1.5751.714","volume":"1","author":"H Smitskamp","year":"1971","unstructured":"Smitskamp, H. & Wolthuis, F. H. New concepts in treatment of malignant tertian malaria with cerebral involvement. British medical journal 1, 714\u2013716 (1971).","journal-title":"British medical journal"},{"key":"BFsrep29317_CR25","doi-asserted-by":"crossref","unstructured":"Severe and complicated malaria. World Health Organization Malaria Action Programme. Trans R Soc Trop Med Hyg 80 Suppl, 3\u201350 (1986).","DOI":"10.1016\/0035-9203(86)90407-4"},{"key":"BFsrep29317_CR26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.4269\/ajtmh.1998.58.122","volume":"58","author":"PR Fischer","year":"1998","unstructured":"Fischer, P. R. & Boone, P. Short report: severe malaria associated with blood group. Am J Trop Med Hyg 58, 122\u2013123 (1998).","journal-title":"Am J Trop Med Hyg"},{"key":"BFsrep29317_CR27","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1093\/hmg\/ddm331","volume":"17","author":"AE Fry","year":"2008","unstructured":"Fry, A. E. et al. Common variation in the ABO glycosyltransferase is associated with susceptibility to severe Plasmodium falciparum malaria. Human molecular genetics 17, 567\u2013576, 10.1093\/hmg\/ddm331 (2008).","journal-title":"Human molecular genetics"},{"key":"BFsrep29317_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1590\/S0074-02762003000400004","volume":"98","author":"B Beiguelman","year":"2003","unstructured":"Beiguelman, B. et al. The association of genetic markers and malaria infection in the Brazilian Western Amazonian region. Mem Inst Oswaldo Cruz 98, 455\u2013460 (2003).","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"BFsrep29317_CR29","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1179\/136485905X19946","volume":"99","author":"SL Pathirana","year":"2005","unstructured":"Pathirana, S. L. et al. ABO-blood-group types and protection against severe, Plasmodium falciparum malaria. Ann Trop Med Parasitol 99, 119\u2013124, 10.1179\/136485905X19946 (2005).","journal-title":"Ann Trop Med Parasitol"},{"key":"BFsrep29317_CR30","doi-asserted-by":"publisher","first-page":"17471","DOI":"10.1073\/pnas.0705390104","volume":"104","author":"JA Rowe","year":"2007","unstructured":"Rowe, J. A. et al. Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Proc Natl Acad Sci USA 104, 17471\u201317476, 10.1073\/pnas.0705390104 (2007).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep29317_CR31","doi-asserted-by":"publisher","first-page":"15487","DOI":"10.1074\/jbc.273.25.15487","volume":"273","author":"D Spillmann","year":"1998","unstructured":"Spillmann, D., Witt, D. & Lindahl, U. Defining the interleukin-8-binding domain of heparan sulfate. J Biol Chem 273, 15487\u201315493 (1998).","journal-title":"J Biol Chem"},{"key":"BFsrep29317_CR32","doi-asserted-by":"publisher","first-page":"23405","DOI":"10.1074\/jbc.M604702200","volume":"281","author":"D Spillmann","year":"2006","unstructured":"Spillmann, D., Lookene, A. & Olivecrona, G. Isolation and characterization of low sulfated heparan sulfate sequences with affinity for lipoprotein lipase. J Biol Chem 281, 23405\u201323413, 10.1074\/jbc.M604702200 (2006).","journal-title":"J Biol Chem"},{"key":"BFsrep29317_CR33","doi-asserted-by":"publisher","first-page":"e50758","DOI":"10.1371\/journal.pone.0050758","volume":"7","author":"D Angeletti","year":"2012","unstructured":"Angeletti, D. et al. Plasmodium falciparum rosetting epitopes converge in the SD3-loop of PfEMP1-DBL1alpha. PLoS One 7, e50758, 10.1371\/journal.pone.0050758 (2012).","journal-title":"PLoS One"},{"key":"BFsrep29317_CR34","doi-asserted-by":"publisher","first-page":"e62906","DOI":"10.1371\/journal.pone.0062906","volume":"8","author":"T Spangenberg","year":"2013","unstructured":"Spangenberg, T. et al. The open access malaria box: a drug discovery catalyst for neglected diseases. PLoS One 8, e62906, 10.1371\/journal.pone.0062906 (2013).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep29317","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep29317.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep29317.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T18:18:47Z","timestamp":1672856327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep29317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,11]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,9,1]]}},"alternative-id":["BFsrep29317"],"URL":"https:\/\/doi.org\/10.1038\/srep29317","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,11]]},"assertion":[{"value":"8 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.W. is a co-founder and board member of Dilaforette, a company developing drugs for severe malaria. All other authors declare no financial conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29317"}}